Financhill
Buy
59

HLIO Quote, Financials, Valuation and Earnings

Last price:
$29.13
Seasonality move :
5.02%
Day range:
$27.12 - $27.78
52-week range:
$24.76 - $57.29
Dividend yield:
1.33%
P/E ratio:
23.19x
P/S ratio:
1.12x
P/B ratio:
1.05x
Volume:
400.2K
Avg. volume:
317.5K
1-year change:
-42.68%
Market cap:
$903.3M
Revenue:
$805.9M
EPS (TTM):
$1.17

Earnings Data

Next earnings date for HLIO
Aug 05
2025
Most recent earnings per share
$0.14
Missed by $0.21
(Feb 24/2025)
Consensus Estimate
$0.35
(Feb 24/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HLIO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/05/2025 Q2 $204.4M -- -- $0.56 --
05/06/2025 Q1 $187.5M -- -- $0.36 --
02/24/2025 Q4 $176.2M $179.5M $0.14 $0.35 -$0.21
11/05/2024 Q3 $196.4M $194.5M $0.34 $0.54 -$0.20
08/05/2024 Q2 $215.8M $219.9M $0.41 $0.61 -$0.20
05/08/2024 Q1 $205.4M $212M $0.28 $0.44 -$0.16
02/26/2024 Q4 $183.9M $193.4M $0.10 $0.27 -$0.17
11/02/2023 Q3 -- -- $0.11 $0.70 -$0.59
08/07/2023 Q2 -- -- $0.51 $0.84 -$0.33
05/08/2023 Q1 -- -- $0.42 $0.77 -$0.35
02/27/2023 Q4 -- -- $0.54 $0.74 -$0.20
11/07/2022 Q3 -- -- $0.63 $0.97 -$0.34
08/08/2022 Q2 -- -- $0.92 $1.17 -$0.25
05/09/2022 Q1 -- -- $0.94 $0.96 -$0.02
02/28/2022 Q4 -- -- $0.72 $0.82 -$0.10
11/08/2021 Q3 -- -- $0.86 $0.80 $0.06
08/09/2021 Q2 -- -- $0.95 $0.86 $0.09
05/10/2021 Q1 -- -- $0.70 $0.75 -$0.05
03/01/2021 Q4 -- -- $0.17 $0.41 -$0.24
11/02/2020 Q3 -- -- $0.40 $0.41 -$0.01
08/03/2020 Q2 -- -- $0.40 $0.27 $0.13
05/04/2020 Q1 -- -- -$0.54 $0.40 -$0.94
02/24/2020 Q4 -- -- $0.43 $0.35 $0.08
11/04/2019 Q3 -- -- $0.40 $0.58 -$0.18
08/05/2019 Q2 -- -- $0.54 $0.64 -$0.10
05/06/2019 Q1 -- -- $0.51 $0.63 -$0.12
02/25/2019 Q4 -- -- $0.51 $0.39 $0.12
11/05/2018 Q3 -- -- $0.36 $0.46 -$0.10
08/06/2018 Q2 -- -- $0.22 -- --
05/07/2018 Q1 -- -- $0.40 -- --
02/26/2018 Q4 -- -- $0.10 -- --
11/06/2017 Q3 -- -- $0.42 -- --
08/07/2017 Q2 -- -- $0.27 -- --
05/08/2017 Q1 -- -- $0.38 -- --
02/27/2017 Q4 -- -- $0.12 -- --
11/07/2016 Q3 -- -- $0.19 -- --
08/04/2016 Q2 -- -- $0.26 -- --
05/10/2016 Q1 -- -- $0.31 -- --
03/01/2016 Q4 -- -- $0.19 -- --
11/03/2015 Q3 -- -- $0.32 -- --
08/03/2015 Q2 -- -- $0.35 -- --

Helios Technologies Earnings Questions

  • How Much did Helios Technologies Generate in Revenue Last Quarter?

    Helios Technologies reported $179.5M worth of top line sales in its most recent quarter.

  • Did Helios Technologies Beat Earnings Last Quarter?

    Helios Technologies announced earnings per share of $0.14 which represents a miss of analyst forecast a $0.35 per share.

  • Is Helios Technologies Profitable?

    Helios Technologies reported $54M that represents $1.61 per share over the last quarter.

  • What is the Analyst Consensus for Helios Technologies EPS Next Year?

    Helios Technologies's earnings are forecast to grow from $1.17 per share to $2.11 per share next year representing an increase of 85.64%.

  • When is Helios Technologies's Earnings Date?

    Helios Technologies's next earnings date is August 5, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is down 0% over the past day.

Buy
53
SRPT alert for May 7

Sarepta Therapeutics [SRPT] is down 21.54% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock